Premier Alternatives

Orchidia Pharmaceutical Industries

Cairo, Egypt · Founded 1993 · Privately Held (backing)

Manufacturer of pharmaceutical ophthalmic, cosmeceutical, and food supplement products intended to support ocular health and overall wellness. Orchidia Pharmaceutical Industries is based in Cairo, Egypt and was founded in 1993. Its last reported valuation was $85.2 million in Nov 2017.

Last reported valuation
$85.2M
Oct 2026
Priced at
—
Total raised
—
Last round
—

Orchidia Pharmaceutical Industries key facts

as of Oct 2026
  • Manufacturer of pharmaceutical ophthalmic, cosmeceutical, and food supplement products intended to support ocular health and overall wellness.
  • Orchidia Pharmaceutical Industries is valued at approximately $85.2M as of Oct 2026 (last reported valuation).
  • Notable investors include European Bank for Reconstruction and Development, Proparco, Belgian Investment Company for Developing Countries, Egyptian-American Enterprise Fund, Lorax Capital Partners.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$85.2M

Orchidia Pharmaceutical Industries's last reported valuation, Nov 2017. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Orchidia Pharmaceutical Industries with a free account
  • ·Watch Orchidia Pharmaceutical Industries: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Orchidia Pharmaceutical Industries funding rounds

No rounds on record

No funding rounds for Orchidia Pharmaceutical Industries are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Orchidia Pharmaceutical Industries valuation

Orchidia Pharmaceutical Industries's last reported valuation was $85.2 million in Nov 2017. No priced round, secondary trade or fund mark has surfaced since.

Orchidia Pharmaceutical Industries investors

5 investors are on record for Orchidia Pharmaceutical Industries, including European Bank for Reconstruction and Development, Proparco, Belgian Investment Company for Developing Countries and Egyptian-American Enterprise Fund.

About Orchidia Pharmaceutical Industries

Manufacturer of pharmaceutical ophthalmic, cosmeceutical, and food supplement products intended to support ocular health and overall wellness. The company offers subconjunctival and intraocular injection solutions, anti-inflammatory eye drops, lens care products, and eye vitamins, enabling healthcare providers and patients to access affordable and consistently available eye care treatments.

Sector
Healthcare
HQ
Cairo, Egypt
Founded
1993
Employees
554
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.